 |
 |
|
|
|
|
|
|
 | | Discovery and development of innovative products for the prevention, treatment and diagnosis of infectious diseases
| | Private
| | 2010
|
 |
 | | Develops powerful synthetic biology platform, SECANT™ System to engineer biotherapeutics
| | Private
| | 2009
|
|
 | | Develops anti-metastatic drugs as a new category of cancer therapeutics
| | Private
| | 2009
|
|
 | | Creating the next generation of protein-based medicines to treat important diseases with unmet needs
| | Private
| | 2010
|
|
 | | Drug discovery and development utilizing pioneering G-protein coupled receptor (GPCR) technology
| | Private
| | 2009
|
|
 | | Developing the first generation of nanoparticle immunomodulatory drugs
| | Private
| | 2008
|
|
 | | Developing novel drugs targeting cancer metabolism
| | Private
| | 2008
|
|
 | | Developing therapeutic targeted nanoparticles
| | Private
| | 2007
|
|
 | | Developing new medicines utilizing deuterium
| | Private
| | 2006
|
|
 | | Developing novel antibiotics to treat drug-resistant infections
| | Private
| | 2006
|
|
 | | Developing new treatments for celiac disease
| | Private
| | 2006
|
|
 | | Developing therapeutics for inflammatory diseases utlizing resolvins
| | Private
| | 2006
|
|
 | | Developing drugs to treat musculoskeletal and metabolic disorders, and cancer-related diseases
| | Private
| | 2004
|
|
 | | Developing platform to synthesize compounds for drug discovery and biodetection
| | Private
| | 2004
|
|
 | | Developing cell-based therapies that induce repair and regeneration in a wide array of tissues
| | Private
| | 2003
|
|
 | | Developing novel, targeted cancer therapeutics
| | Private
| | 2003
|
|
